Esketamine as a treatment for paediatric depression: questions of safety and efficacy

Lancet Psychiatry. 2020 Oct;7(10):827-829. doi: 10.1016/S2215-0366(19)30521-8. Epub 2020 Jan 14.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use*
  • Child
  • Depressive Disorder, Treatment-Resistant / drug therapy*
  • Humans
  • Ketamine / adverse effects
  • Ketamine / therapeutic use*

Substances

  • Antidepressive Agents
  • Esketamine
  • Ketamine